Scribe Therapeutics has put its IPO plans down on paper, showing the genetic medicine company hopes to raise $96 million through its public listing. | Scribe Therapeutics has put its IPO plans down on ...

Why this 2-year-old San Francisco company filed for an IPO © 2026 American City Business Journals. All rights reserved. Use ...

The Kindle Scribe Without Front Light should be an ideal e-ink notebook, but it's limits are hard to ignore. Find out more in ...

The newest Kindle Scribe means there are now three digital notebooks you can buy in the $400 price range. Here’s which one you should get.

Readers & writers rejoice ...

It has the write idea though ...

We may receive a commission on purchases made from links. When I turned 10, I was finally allowed to own a pen. At school, that was when we moved from pencils to ink, and our parents were told to get ...

Executive Editor David Carnoy has been a leading member of CNET's Reviews team since 2000. He covers the gamut of gadgets and is a notable reviewer of mobile accessories and portable audio products, ...

I’m PCMag’s home theater and AR/VR expert, and your go-to source of information and recommendations for game consoles and accessories, smart displays, smart glasses, smart speakers, soundbars, TVs, ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Scribe Therapeutics Inc., a molecular engineering company creating the most advanced technologies for CRISPR-based genetic medicine, today announced the completion of ...

The $79/month plan gives individual dental providers dental-only drafted notes, diarized transcript context, and simple ...

ModMed®, a leading provider of software and services to specialty medical practices, today announced that its AI-powered clinical documentation solution, ModMed Scribe 2.0, has been used in more than ...